Israeli firm gets U.S. nod for advanced trials for non-opiate painkiller
JERUSALEM (Reuters) - Israeli pharmaceuticals company PainReform has received approval from the U.S. Food and Drug Administration (FDA) to begin late-stage clinical studies for a...